Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Shared Decision Making on Immunotherapy in Oncology - Prospective, Randomized, Controlled Trial

NCT04240717 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.

NCT NCT04240717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04240717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Shared Decision Making on Immunotherapy in Oncology - Prospective, Randomized, Controlled Trial
Lead sponsor
University Hospital Heidelberg
Phase
Not applicable
Overall status
Completed
Start date
February 7, 2020
Completion date
October 8, 2022
Enrollment
126 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

patient decision aid, treatment as usual